# Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity

> **NCT01148667** · PHASE4 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Gut Microbiota
- Skin Microbiota
- Humoral Immune Responses
- Severity of Atopic Dermatitis

## Interventions

- **DIETARY_SUPPLEMENT:** Casein hydrolysate added with LGG
- **DIETARY_SUPPLEMENT:** Infants drink casein hydrolysate without LGG

## Key facts

- **NCT ID:** NCT01148667
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-06-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148667, "Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01148667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*